Literature DB >> 19131996

Crossing the rubicon.

Pedro R Lowenstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19131996      PMCID： PMC2703653          DOI： 10.1038/nbt0109-42

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  10 in total

Review 1.  Immunology of viral-vector-mediated gene transfer into the brain: an evolutionary and developmental perspective.

Authors:  Pedro R Lowenstein
Journal:  Trends Immunol       Date:  2002-01       Impact factor: 16.687

2.  AAV transcytosis through barrier epithelia and endothelium.

Authors:  Giovanni Di Pasquale; John A Chiorini
Journal:  Mol Ther       Date:  2005-12-20       Impact factor: 11.454

3.  What is the blood-brain barrier (not)?

Authors:  Ingo Bechmann; Ian Galea; V Hugh Perry
Journal:  Trends Immunol       Date:  2006-11-30       Impact factor: 16.687

Review 4.  Exploiting circuit-specific spread of pseudorabies virus in the central nervous system: insights to pathogenesis and circuit tracers.

Authors:  L W Enquist
Journal:  J Infect Dis       Date:  2002-12-01       Impact factor: 5.226

5.  Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain.

Authors:  Haiyan Fu; Joseph Muenzer; Richard J Samulski; George Breese; Jerillyn Sifford; Xinhua Zeng; Douglas M McCarty
Journal:  Mol Ther       Date:  2003-12       Impact factor: 11.454

Review 6.  Image-guided convection-enhanced delivery platform in the treatment of neurological diseases.

Authors:  Massimo S Fiandaca; John R Forsayeth; Peter J Dickinson; Krystof S Bankiewicz
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

7.  Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

Authors:  Kevin D Foust; Emily Nurre; Chrystal L Montgomery; Anna Hernandez; Curtis M Chan; Brian K Kaspar
Journal:  Nat Biotechnol       Date:  2008-12-21       Impact factor: 54.908

8.  A single injection of an adeno-associated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease.

Authors:  Cassia N Cearley; John H Wolfe
Journal:  J Neurosci       Date:  2007-09-12       Impact factor: 6.167

9.  AAV vector integration sites in mouse hepatocellular carcinoma.

Authors:  Anthony Donsante; Daniel G Miller; Yi Li; Carole Vogler; Elizabeth M Brunt; David W Russell; Mark S Sands
Journal:  Science       Date:  2007-07-27       Impact factor: 47.728

10.  Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.

Authors:  Catherine S Manno; Glenn F Pierce; Valder R Arruda; Bertil Glader; Margaret Ragni; John J Rasko; John Rasko; Margareth C Ozelo; Keith Hoots; Philip Blatt; Barbara Konkle; Michael Dake; Robin Kaye; Mahmood Razavi; Albert Zajko; James Zehnder; Pradip K Rustagi; Hiroyuki Nakai; Amy Chew; Debra Leonard; J Fraser Wright; Ruth R Lessard; Jürg M Sommer; Michael Tigges; Denise Sabatino; Alvin Luk; Haiyan Jiang; Federico Mingozzi; Linda Couto; Hildegund C Ertl; Katherine A High; Mark A Kay
Journal:  Nat Med       Date:  2006-02-12       Impact factor: 53.440
  10 in total
  6 in total

1.  The neonatal blood-brain barrier is functionally effective, and immaturity does not explain differential targeting of AAV9.

Authors:  Norman R Saunders; C Joakim Ek; Katarzyna M Dziegielewska
Journal:  Nat Biotechnol       Date:  2009-09       Impact factor: 54.908

2.  Over the barrier and through the blood: to CNS delivery we go.

Authors:  Kevin D Foust; Brian K Kaspar
Journal:  Cell Cycle       Date:  2009-12-05       Impact factor: 4.534

3.  Distinct transduction profiles in the CNS via three injection routes of AAV9 and the application to generation of a neurodegenerative mouse model.

Authors:  Fathul Huda; Ayumu Konno; Yasunori Matsuzaki; Hanna Goenawan; Koichi Miyake; Takashi Shimada; Hirokazu Hirai
Journal:  Mol Ther Methods Clin Dev       Date:  2014-08-06       Impact factor: 6.698

4.  MiR-298 Counteracts Mutant Androgen Receptor Toxicity in Spinal and Bulbar Muscular Atrophy.

Authors:  Naemeh Pourshafie; Philip R Lee; Ke-Lian Chen; George G Harmison; Laura C Bott; Masahisa Katsuno; Gen Sobue; Barrington G Burnett; Kenneth H Fischbeck; Carlo Rinaldi
Journal:  Mol Ther       Date:  2016-01-12       Impact factor: 11.454

Review 5.  Systemic gene delivery to the central nervous system using Adeno-associated virus.

Authors:  Mathieu Bourdenx; Nathalie Dutheil; Erwan Bezard; Benjamin Dehay
Journal:  Front Mol Neurosci       Date:  2014-06-02       Impact factor: 5.639

6.  Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents.

Authors:  Naemeh Pourshafie; Philip R Lee; Ke-Lian Chen; George G Harmison; Laura C Bott; Kenneth H Fischbeck; Carlo Rinaldi
Journal:  J Vis Exp       Date:  2018-08-10       Impact factor: 1.355
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.